Mode
Text Size
Log in / Sign up

Systematic review of post-traumatic growth in 6382 breast cancer patientsPost-traumatic growth is common among breast cancer survivors and linked to better coping

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that post-traumatic growth is common among breast cancer survivors and linked to resilience.

This systematic review and meta-analysis evaluates post-traumatic growth (PTG) within a population of 6382 breast cancer patients. The study setting was not reported in the source data. The authors analyze the prevalence of PTG and its connections to secondary outcomes such as psychological distress, coping, and resilience.

The analysis reveals that PTG is an almost ubiquitous experience among breast cancer survivors. Additionally, a positive association is observed between PTG and coping or resilience. The data also indicates a notable relationship suggesting these processes may be interconnected. No specific effect sizes or absolute numbers were reported for these outcomes.

The review does not report adverse events, discontinuations, or tolerability data. Limitations regarding the study setting and specific follow-up duration were not reported. The authors refrain from causal language, noting instead that the evidence points to associations rather than direct effects. Practice relevance is not explicitly detailed in the source material.

A systematic review examined post-traumatic growth in breast cancer patients. The analysis included data from 6,382 survivors. The researchers looked at how often this experience occurs and how it relates to mental health outcomes.

The study found that post-traumatic growth is an almost ubiquitous experience among these survivors. This means most people who survive breast cancer report finding positive changes after their illness. The review also looked at connections to psychological distress, coping, and resilience.

Results showed a notable relationship between post-traumatic growth and psychological distress, suggesting these processes may be interconnected. Additionally, there was a positive association between post-traumatic growth and coping or resilience. The evidence comes from a meta-analysis, which combines results from many studies to provide a broader view. No safety concerns were reported because the research focused on mental health patterns rather than medical treatments. Readers should understand that while these findings are encouraging, they describe associations rather than proving that one thing causes another. This information helps survivors and caregivers understand the emotional landscape after cancer.

What this means for you:
Most breast cancer survivors experience post-traumatic growth, which is linked to better coping and resilience.

Study Details

Study typeMeta analysis
Sample sizen = 6,382
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Breast cancer patients navigate a challenging and complex journey that often involves both emotional and physical struggles. Despite the challenges, their journey leads to significant personal growth. To gain understanding of the psychological dimensions of this experience, this study systematically reviews previously published research on breast cancer. Specifically, it incorporates three meta-analyses to investigate the relationships among post-traumatic growth (PTG), psychological distress, coping, and resilience. The review includes 33 studies with a combined sample of 6382 patients. The findings reveal three key insights. First, PTG is an almost ubiquitous experience among breast cancer survivors. Second, there is a notable relationship between PTG and psychological distress, indicating that these processes may be interconnected. Third, PTG shows a positive association with coping and resilience, highlighting the importance of these factors in fostering growth. These results emphasize the significant role that psychological factors, like resilience and coping, play in facilitating PTG in breast cancer patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.